The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic
- 1 December 1992
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 32 (6) , 795-798
- https://doi.org/10.1002/ana.410320614
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Selegiline as initial treatment in de novo parkinsonian patientsNeurology, 1992
- Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slowAnnals of Neurology, 1991
- Probability distributions in reliabilityPublished by Springer Nature ,1991
- Possible mechanism of action of deprenyl in parkinsonismThe Lancet, 1990
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's DiseaseScience, 1989
- Splines in StatisticsJournal of the American Statistical Association, 1983
- Estimating survival functions from the life tableJournal of Chronic Diseases, 1969
- Estimation of Mortality Intensities in Animal ExperimentsPublished by JSTOR ,1960
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958